InsiderTrades.com logo

IMMX Insider Trading

Insider Ownership Percentage: 55.40%
Insider Buying (Last 12 Months): $20,232.62
Insider Selling (Last 12 Months): $0.00

Immix Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Immix Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immix Biopharma Share Price & Price History

Current Price: $4.84
Price Change: ▲ Price Increase of +0.69 (16.63%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for IMMX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Immix Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/17/2025Ilya M RachmanCEOBuy2,500$2.02$5,050.001,140,937View SEC Filing Icon  
9/16/2025Gabriel S MorrisCFOBuy2,600$1.97$5,122.00290,659View SEC Filing Icon  
6/18/2025Gabriel S MorrisCFOBuy2,225$2.28$5,073.00288,059View SEC Filing Icon  
6/18/2025Ilya M RachmanCEOBuy2,178$2.29$4,987.621,138,437View SEC Filing Icon  
8/16/2024Carey NgDirectorBuy10,000$1.86$18,600.0020,000View SEC Filing Icon  
7/24/2024Jason HsuDirectorBuy6,000$2.15$12,900.00822,200View SEC Filing Icon  
7/18/2024Jason HsuDirectorBuy3,200$2.07$6,624.00816,200View SEC Filing Icon  
6/7/2024Gabriel S MorrisCFOBuy2,500$2.12$5,300.00285,834View SEC Filing Icon  
6/7/2024Ilya M RachmanCEOBuy2,600$2.13$5,538.001,136,259View SEC Filing Icon  
6/4/2024Gabriel S MorrisCFOBuy3,300$1.81$5,973.00283,334View SEC Filing Icon  
5/14/2024Gabriel S MorrisCFOBuy4,500$2.23$10,035.0085,816View SEC Filing Icon  
5/14/2024Ilya M RachmanCEOBuy4,300$2.25$9,675.00912,000View SEC Filing Icon  
12/11/2023Jason HsuDirectorBuy31,000$4.67$144,770.00813,000View SEC Filing Icon  
12/8/2023Jason HsuDirectorBuy25,000$4.88$122,000.00782,000View SEC Filing Icon  
9/14/2023Carey NgDirectorBuy10,000$2.58$25,800.0010,000View SEC Filing Icon  
9/12/2023Helen C AdamsDirectorBuy13,000$2.96$38,480.0013,000View SEC Filing Icon  
9/7/2023Melissa Jane BuchanDirectorBuy20,000$2.46$49,200.0020,000View SEC Filing Icon  
9/5/2023Magda MarquetDirectorBuy10,000$2.47$24,700.0011,000View SEC Filing Icon  
8/31/2023Magda MarquetDirectorBuy1,000$2.01$2,010.001,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Immix Biopharma (NASDAQ:IMMX)

11.26% of Immix Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMMX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Immix Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025United Capital Financial Advisors LLC70,682$0.15M0.0%N/A0.211%Search for SEC Filing on Google Icon
11/17/2025Velan Capital Investment Management LP35,000$73K0.1%+40.0%0.104%Search for SEC Filing on Google Icon
11/17/2025Susquehanna International Group LLP90,858$0.19M0.0%+78.8%0.271%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC89,798$0.19M0.0%N/A0.267%Search for SEC Filing on Google Icon
11/14/2025Imprint Wealth LLC67,423$0.14M0.5%N/A0.201%Search for SEC Filing on Google Icon
11/13/2025Tocqueville Asset Management L.P.40,250$84K0.0%+37.4%0.120%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.730,162$1.53M0.0%+4.5%2.210%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP25,000$52K0.1%N/A0.087%Search for SEC Filing on Google Icon
7/17/2025Tritonpoint Wealth LLC24,526$51K0.0%N/A0.088%Search for SEC Filing on Google Icon
5/13/2025Tocqueville Asset Management L.P.29,300$49K0.0%-23.5%0.105%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC17,523$39K0.0%N/A0.064%Search for SEC Filing on Google Icon
2/6/2025SBI Securities Co. Ltd.17,500$38K0.0%N/A0.064%Search for SEC Filing on Google Icon
1/13/2025FNY Investment Advisers LLC28,750$63K0.0%N/A0.105%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC150,082$0.22M0.0%+5.6%0.546%Search for SEC Filing on Google Icon
10/22/2024Private Advisor Group LLC34,325$51K0.0%-47.3%0.130%Search for SEC Filing on Google Icon
8/16/2024Invst LLC27,000$57K0.0%N/A0.102%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd17,663$35K0.0%-66.2%0.067%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC154,685$0.31M0.0%-41.7%0.586%Search for SEC Filing on Google Icon
8/7/2024AIGH Capital Management LLC1,406,680$2.79M0.9%-9.5%5.326%Search for SEC Filing on Google Icon
5/10/2024Tocqueville Asset Management L.P.37,800$0.12M0.0%+89.0%0.143%Search for SEC Filing on Google Icon
4/26/2024Tritonpoint Wealth LLC24,526$75K0.0%N/A0.093%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC18,500$0.13M0.0%N/A0.093%Search for SEC Filing on Google Icon
2/6/2024Private Advisor Group LLC99,775$0.69M0.0%N/A0.502%Search for SEC Filing on Google Icon
2/1/2024OLD National Bancorp IN10,000$69K0.0%N/A0.050%Search for SEC Filing on Google Icon
1/30/2024Imprint Wealth LLC34,483$0.24M0.2%+49.4%0.174%Search for SEC Filing on Google Icon
11/9/2023Tocqueville Asset Management L.P.12,000$41K0.0%N/A0.061%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC28,855$99K0.0%+26.4%0.147%Search for SEC Filing on Google Icon
7/28/2023Koshinski Asset Management Inc.51,001$0.14M0.0%N/A0.339%Search for SEC Filing on Google Icon
7/25/2023UMB Bank n.a.72,639$0.20M0.0%-26.8%0.483%Search for SEC Filing on Google Icon
4/11/2023UMB Bank n.a.99,300$0.18M0.0%N/A0.714%Search for SEC Filing on Google Icon
2/10/2023Murchinson Ltd.67,200$0.15M0.0%N/A0.482%Search for SEC Filing on Google Icon
2/7/2023Lynwood Capital Management Inc.25,000$58K0.1%N/A0.179%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can15,000$36K0.0%N/A0.108%Search for SEC Filing on Google Icon
5/11/2022InterOcean Capital Group LLC15,900$38K0.0%N/A0.115%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP122,388$0.44M0.1%N/A1.616%Search for SEC Filing on Google Icon
2/14/2022Murchinson Ltd.695,600$2.48M0.2%N/A9.183%Search for SEC Filing on Google Icon
2/9/2022Context Capital Management LLC11,532$41K0.0%N/A0.152%Search for SEC Filing on Google Icon
2/2/2022PVG Asset Management Corp20,000$71K0.3%N/A0.264%Search for SEC Filing on Google Icon
2/1/2022Eidelman Virant Capital29,856$0.10M0.0%N/A0.394%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Immix Biopharma logo
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Read More on Immix Biopharma

Today's Range

Now: $4.84
Low: $4.07
High: $5.08

50 Day Range

MA: $3.33
Low: $2.06
High: $4.84

52 Week Range

Now: $4.84
Low: $1.34
High: $5.08

Volume

1,226,575 shs

Average Volume

554,986 shs

Market Capitalization

$162.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Immix Biopharma?

Immix Biopharma's top insider investors include:
  1. Ilya M Rachman (CEO)
  2. Jason Hsu (Director)
  3. Gabriel S Morris (CFO)
  4. Carey Ng (Director)
Learn More about top insider investors at Immix Biopharma.

Who are the major institutional investors of Immix Biopharma?

Immix Biopharma's top institutional shareholders include:
  1. Vanguard Group Inc. — 2.21%
  2. Susquehanna International Group LLP — 0.27%
  3. Citadel Advisors LLC — 0.27%
  4. United Capital Financial Advisors LLC — 0.21%
  5. Imprint Wealth LLC — 0.20%
  6. Tocqueville Asset Management L.P. — 0.12%
Learn More about top institutional investors of Immix Biopharma stock.

Which major investors are buying Immix Biopharma stock?

In the last quarter, IMMX stock was bought by institutional investors including:
  1. Citadel Advisors LLC
  2. United Capital Financial Advisors LLC
  3. Imprint Wealth LLC
  4. Susquehanna International Group LLP
  5. Vanguard Group Inc.
  6. Tocqueville Asset Management L.P.
  7. Velan Capital Investment Management LP
Within the previous year, these company insiders have bought Immix Biopharma stock:
  1. Ilya M Rachman (CEO)
  2. Jason Hsu (Director)
  3. Gabriel S Morris (CFO)
  4. Carey Ng (Director)
Learn More investors buying Immix Biopharma stock.